Homology Medicines, Inc.

(FIXX) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Homology Holdings Class Action Lawsuit

SAN DIEGO- Globe Newswire —March 29, 2022

Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Homology Medicines, Inc. (NASDAQ: FIXX). The class action is on behalf of shareholders who purchased Homology securities between June 10, 2019 and February 18, 2022, inclusive (the “Class Period”). To serve as lead plaintiff in this class action, you must move the Court no later than May 24, 2022.

What actions may I take at this time? If you suffered a substantial loss and are interested in learning more about being a lead plaintiff, please contact Jim Baker (jimb@johnsonfistel.com) by email or phone at 619-814-4471. If emailing, please include a phone number.

To join this action, you can click or copy and paste the link below in a browser:


There is no cost or obligation to you.

The complaint alleges investors began to learn the truth on July 21, 2020, when Mariner Research published a report bringing Homology’s statements about the efficacy of HMI-102 into serious question. Mariner concluded in part that the Company concealed data showing HMI-102 is not efficacious for high dose Cohort 3 patients and the program is likely worthless and unlikely to proceed to commercialization. Mariner’s report also cited an e-mail from the Company’s Chief Communications Officer indicating the company was aware of a HMI-102 high dose patient’s having posted the adverse efficacy issue on social media during April 2020.

A lead plaintiff will act on behalf of all other class members in directing the Homology class-action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the class-action lawsuit. An investor’s ability to share any potential future recovery of the Homology class action lawsuit is not dependent upon serving as lead plaintiff.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. Johnson Fistel seeks to recover losses incurred due to violations of federal securities laws. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Johnson Fistel, LLP
Jim Baker, 619-814-4471
Investor Relations